Marshall Wace’s T2 Biosystems, Inc TTOO Stock Holding History

Marshall Wace’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-40	Closed	-$506K	–	2162
2019 Q3	$506K	Buy	+40	New	+$321K	﹤0.01%	1107

Other funds holding TTOO

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace's TTOO Position: Q4 2019 in Review

Marshall Wace sold out of T2 Biosystems, Inc (TTOO) in Q4 2019, closing a stake of 40 shares — an estimated $506K sold.

Marshall Wace first reported a position in TTOO in Q3 2019 and held it in 1 quarter. The position peaked at $506K in Q3 2019. 43 funds tracked by Wall St. Rank hold TTOO as of Q4 2019.

Marshall Wace reported no remaining T2 Biosystems, Inc position as of Q4 2019 after selling out during the quarter.
Marshall Wace sold 40 T2 Biosystems, Inc shares in Q4 2019, an estimated $506K.
Marshall Wace first reported a position in T2 Biosystems, Inc in Q3 2019 and held it in 1 quarter.
Marshall Wace's T2 Biosystems, Inc position peaked at $506K in Q3 2019.
43 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2019.

Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.